Abstract

https://ssrn.com/abstract=1544017
 
 

Footnotes (29)



 


 



The Enigma of Clearing Buy Side OTC Derivatives


Christian A. Johnson


Widener University - Commonwealth Law School

December 1, 2009

Futures and Derivatives Law Report, Vol. 29, No. 11, December 2009

Abstract:     
Congress is currently debating whether to mandate the clearing of buy side OTC derivatives. Such an action, however, represents a seismic and unproven shift in how OTC derivatives function and how they are traded, processed and assessed, especially with respect to the highly customized products that are developed for the buy side. This article summarizes the various practical concerns implicated in such a requirement and questions whether the clearing requirement will stifle the use of OTC derivatives and whether aggregate risk will be reduced.

Number of Pages in PDF File: 11

Keywords: derivatives, clearing, clearinghouse, regulated central counterparty, exchange, futures

JEL Classification: D40, E44, E52, G28


Open PDF in Browser Download This Paper

Date posted: February 5, 2010  

Suggested Citation

Johnson, Christian A., The Enigma of Clearing Buy Side OTC Derivatives (December 1, 2009). Futures and Derivatives Law Report, Vol. 29, No. 11, December 2009. Available at SSRN: https://ssrn.com/abstract=1544017

Contact Information

Christian A. Johnson (Contact Author)
Widener University - Commonwealth Law School ( email )
3800 Vartan Way
Harrisburg, PA 17110-9380
United States
717.541.3902 (Phone)

Feedback to SSRN


Paper statistics
Abstract Views: 1,500
Downloads: 391
Download Rank: 56,641
Footnotes:  29